Form 8-K - Current report:
SEC Accession No. 0001104659-26-081579
Filing Date
2026-07-08
Accepted
2026-07-08 08:05:31
Documents
13
Period of Report
2026-07-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2619975d1_8k.htm   iXBRL 8-K 34218
2 EXHIBIT 99.1 tm2619975d1_ex99-1.htm EX-99.1 11892
  Complete submission text file 0001104659-26-081579.txt   275674

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tdacu-20260706.xsd EX-101.SCH 4373
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tdacu-20260706_def.xml EX-101.DEF 27841
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tdacu-20260706_lab.xml EX-101.LAB 38246
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tdacu-20260706_pre.xml EX-101.PRE 26461
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2619975d1_8k_htm.xml XML 7243
Mailing Address 52 E 83RD ST. NEW YORK NY 10028
Business Address 52 E 83RD ST. NEW YORK NY 10028 (413) 204-2769
Translational Development Acquisition Corp. (Filer) CIK: 0001926599 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42451 | Film No.: 261160803
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)